Healthcare Services Group, Inc.
NASDAQ:HCSGMedical - Care Facilities
+$0.39 today
- Market cap
- $1.69B
- Beta
- 0.83
- P/E (TTM)
- 23.4
- EPS (TTM)
- $0.97
Volume 0.62M
Average 0.69M
HCSG Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Healthcare Services Group, Inc.NASDAQ: HCSG
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $3.85M fell 0.6% year over year, behind the +12.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 0.4% from the prior quarter. Over 3 fiscal years it compounded at +3.7% a year.
Context
- Depreciation & amortization amounted to 0.9% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -0.6% toward the trailing-twelve-month pace of +12.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 17.07M USD
- Year-over-year change
- +17.1%
- 4-year CAGR
- +3.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 17.07M | +17.1% |
| FY2024 | 2024-12-31 | 14.59M | +1.7% |
| FY2023 | 2023-12-31 | 14.34M | -6.3% |
| FY2022 | 2022-12-31 | 15.32M | +4.4% |
| FY2021 | 2021-12-31 | 14.67M | — |
Depreciation & Amortization vs competitors
How HCSG compares with its peers on the latest reported figures
- HCSG's LTM Mar 2026 depreciation & amortization of $16.75M is the 8th largest of the 11 companies compared; the peer median is $41.36M.
- Its year-over-year change of +12.2% is the 2nd highest of 11, against a peer median of -8.0%.
- Depreciation & amortization amounts to 0.9% of revenue for HCSG, versus a peer median of 4.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $416.38M | +10.6% | +2.8% | 14.6% | |
| LTM Mar 2026 | $140.3M | -24.0% | -12.0% | 2.5% | |
| LTM Aug 2026 | $117.65M | -5.8% | +8.7% | 13.3% | |
| LTM Mar 2026 | $82.56M | +10.8% | +16.3% | 10.5% | |
| LTM Mar 2026 | $60.2M | -10.3% | +2.2% | 4.4% | |
| LTM Mar 2026 | $22.52M | +10.1% | +14.9% | 3.1% | |
| LTM Mar 2026 | $22.34M | -50.0% | -1.7% | 3.7% | |
| LTM Mar 2026 | $16.75M | +12.2% | +3.7% | 0.9% | |
| LTM Mar 2026 | $12.91M | +93.3% | +20.3% | 1.3% | |
| LTM Jan 2026 | $8.22M | -14.7% | — | 9.8% | |
| LTM Mar 2026 | $1.05M | -922.8% | — | — | |
| Peer median (excluding HCSG) | $41.36M | -8.0% | +5.8% | 4.4% | |
Competitors are the stored peer set for HCSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 45.86M | 34.63M | 38.39M | 39.47M | 59.06M |
| Depreciation & Amortization | 14.67M | 15.32M | 14.34M | 14.59M | 17.07M |
| Deferred Income Tax | 3.07M | 5.05M | (4.82M) | (2.94M) | 19.2M |
| Stock-Based Compensation | 8.83M | 9.21M | 8.99M | 9.17M | 12.01M |
| Change in Working Capital | (43.15M) | (114.77M) | (44.16M) | (70.19M) | (40.55M) |
| Accounts Receivables | (37.19M) | (78.71M) | (74.56M) | (61.81M) | 5.23M |
| Inventory | 5.6M | 4.85M | 2.69M | 1.73M | (48K) |
| Accounts Payables | 10.24M | (13.75M) | 7.43M | (9.74M) | (12.06M) |
| Other Working Capital | (21.81M) | (27.17M) | 20.28M | (374K) | (33.66M) |
| Other Non-Cash Items | 7.83M | 42.4M | 30.77M | 40.72M | 78.18M |
| Operating Cash Flow | 37.11M | (8.17M) | 43.5M | 30.8M | 144.97M |
| Capital Expenditures | (5.69M) | (5.21M) | (5.41M) | (6.34M) | (5.82M) |
| Acquisitions (Net) | (23.88M) | (114K) | 0 | (2.75M) | (7.15M) |
| Purchases of Investments | (20.34M) | (2.88M) | 0 | (52.09M) | (21.34M) |
| Sales of Investments | 26.7M | 10.39M | 1.99M | 67.01M | 23.21M |
| Other Investing Activities | 211K | 393K | 121K | 211K | 105K |
| Investing Cash Flow | (22.99M) | 2.58M | (3.29M) | 6.05M | (11M) |
| Debt Repayment | 0 | 25M | 0 | (25M) | 0 |
| Common Stock Issued | 92K | 106K | 0 | 0 | 0 |
| Common Stock Repurchased | (21.54M) | 0 | (11.28M) | (5.02M) | (61.59M) |
| Dividends Paid | (62.23M) | (63.37M) | 0 | 0 | 0 |
| Other Financing Activities | 1.02M | (661K) | (871K) | (1.03M) | (1.74M) |
| Financing Cash Flow | (82.65M) | (38.93M) | (12.15M) | (31.05M) | (63.33M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (68.54M) | (44.52M) | 28.05M | 5.8M | 70.64M |
| Free Cash Flow | 31.42M | (13.38M) | 38.09M | 24.47M | 139.15M |
Healthcare Services Group, Inc.
NASDAQ:HCSG
Intrinsic Alpha fair value
Locked
Current Price
$25.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.